References
- Chapman RW, Arborgh BÅ, Rhodes RM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870–7
- Sivak MV, Farmer RG, Lain AF. Sclerosing cholangitis: its increasing frequency of recognition and association with inflammatory bowel disease. J Clin Gastroenterol 1981; 3: 261–6
- Binder V, Both H, Hansen PK, Hendriksen C, Kreiner S, Torp-Pedersen K. Incidence and prevalence of ulcerative colitis and Crohn's disease in the county of Copenhagen,1962 to 1978. Gastroenterology 1982; 83: 563–8
- Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen. Gut 1985; 26: 158–63
- Schrumpf E, Elgjo K, Fausa O, et al. Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol 1980; 15: 689–97
- Olsson R, Danielsson Å, Järnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 1319–23
- Wewer V, Gluud C, Schlicting P, Burchardt F, Binder V. Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowel disease. Scand J Gastroenterol 1991; 26: 97–102
- Balasubramaniam K, Wiesner RH, La Russo NF. Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology 1988; 95: 1395–8
- Shepard HA, Selby WS, Chapman RWG, et al. Ulcerative colitis and persistent liver dysfunction. Q J Med 1983; 52: 503–13
- Wiesner RH, La Russo NF. Clinocopathological features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 200–6
- Aadland E, Schrumpf E, Fausa O, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987; 22: 655–64
- Mir-Madjlessi SH, Farmer RG, Sivak MV. Bile duct carcinoma in patients with ulcerative colitis. Dig Dis Sci 1987; 32: 145–54
- Broomé U, Glaumann H, Hultcrantz R, Forsum U. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis. Scand J Gastroenterol 1990; 25: 54–8
- Chapman RW, Cottone M, Selby WS, Sheperd HA, Sherlock S, Jewell DP. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut 1986; 27: 86–91
- Snook JA, de Silva HJ, Jewell DP. The association of autoimmune disorders with inflammatory bowel disease. Q J Med 1989; 269: 835–40
- Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 1990; 322: 1842–4
- Grunnet N, Rasmussen HH, Tage-Jensen U, Rasmussen SN. Is primary sclerosing cholangitis associated with HLA-DRw52a?. Tissue Antigen 1991; 38: 133–6
- Ludwig J, Barham SS, La Russo NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981; 6: 632–40
- Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 4: 430–6
- Kolmannskog F, Aakhus T, Fausa O, et al. Cholangiographic findings in ulcerative colitis. Acta Radiol 1981; 22: 156–9
- Wilkinson MI, Donaldson PT, Portmann BC, et al. Prognostic factors in primary sclerosing cholangitis (PSC) value of HLA testing. J Hepatol 1987; 5: S222, Suppl 1